KLRK1 and non-small cell lung carcinoma: Furthermore, NKG2D CAR-T cells from healthy donors or NSCLC patients’ peripheral blood induced tumor shrinkage, improved survival, increased body weight, increased tumor-infiltrating capacity, and elevated serum IFN-γ levels in mice.